ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 44 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | -60.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $5,000 | +25.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -42.9% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $7,000 | +16.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | +50.0% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $4,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 339,796 | $163,000 | 0.04% |
| Malaga Cove Capital, LLC | 30,000 | $14,000 | 0.01% |
| Summit X, LLC | 35,000 | $16,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 75,000 | $36,000 | 0.01% |
| INTRUST BANK NA | 40,000 | $19,000 | 0.01% |
| Fosun International Ltd | 168,851 | $78,000 | 0.01% |
| Truvestments Capital LLC | 11,648 | $6,000 | 0.01% |
| DLD Asset Management, LP | 140,660 | $68,000 | 0.00% |
| Hartford Financial Management Inc. | 18,000 | $9,000 | 0.00% |
| SNS Financial Group, LLC | 26,000 | $12,000 | 0.00% |